You may have thought that once the AAC evaluation was done, the next step was to complete the paperwork required by insurance to request purchase of the device. Instead, you have just been told there needs to be a trial period. What is a trial period? At its...
We are thrilled to announce that NeuroNode®, our groundbreaking access solution, has been recognized with its own unique billing identifier code in the USA. This decision reflects the NeuroNode’s importance and versatility in the assistive technology field. This...
Control Bionics is thrilled to announce it has been awarded one of the prestigious ALS Association 2023 Assistive Technology Grants. The ALS Association is the leading ALS organization in the world and is working to make ALS a livable disease while urgently searching...
Introducing Max Bailey-Jensen! Max’s unwavering determination and use of assistive technologies have allowed him to defy his disability and strive towards Olympic participation. His remarkable journey serves as an inspiration, showcasing the power of resilience...
The launch of DROVE, the world’s first autonomous driving wheelchair module created by Control Bionics, was an exciting event that garnered a lot of press and attention. The keynote speaker, Jeremy Steele, the CEO of Control Bionics, introduced DROVE to the world and...
